- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Pulmonary; Hypertension in Chile
Total 162 results
-
AstraZenecaINCUNA (Scientific and Technical partner)Active, not recruitingPulmonary NodulesBrazil, Mexico, Argentina, Chile, Panama, Colombia, Costa Rica, Dominican Republic
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseChina, Argentina, Taiwan, Chile
-
SanofiCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Chile, Mexico
-
AstraZenecaCompletedChronic Obstructive Pulmonary Disease COPDUnited States, Netherlands, Argentina, South Africa, Chile, Peru
-
SanofiCompletedHypertensionBrazil, Chile, Colombia, Egypt, Lebanon, Mexico, Morocco, Tunisia, Venezuela
-
BackBeat Medical IncMassachusetts General Hospital; MLM Medical Labs GmbH; nabios GmbHCompletedBradycardia | Atrioventricular Block | Hypertension Resistant to Conventional TherapyHungary, Austria, Chile, Latvia, Czechia, Lithuania, Netherlands
-
Novartis PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseArgentina, Dominican Republic, Panama, Mexico, Brazil, Chile, Ecuador, Honduras
-
Boehringer IngelheimCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Australia, Austria, Belgium, Canada, Chile, Germany, Italy, New Zealand
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Spain, Chile, Germany, Korea, Republic of, Bulgaria, Brazil, Slovakia
-
PfizerCompletedChronic Obstructive Pulmonary DiseaseAustralia, Netherlands, Canada, Korea, Republic of, Argentina, Hungary, South Africa, France, Russian Federation, Chile, Czechia, Greece, United Kingdom
-
SanofiRegeneron PharmaceuticalsCompletedChronic Obstructive Pulmonary DiseaseUkraine, Argentina, Chile, Poland, Russian Federation, Turkey, United States, Australia, Canada, Germany
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Costa Rica, Brazil, Chile, Mexico, Argentina
-
TakedaCompletedHypertensionUnited States, Chile, Mexico
-
PfizerTerminatedPulmonary Disease, Chronic ObstructiveAustralia, Canada, Czech Republic, Croatia, Spain, Hungary, Argentina, Singapore, United Kingdom, Chile
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Slovakia
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Argentina, Chile, Romania, Canada
-
Daiichi Sankyo, Inc.CompletedCachexiaUnited States, Argentina, Chile, Guatemala, Honduras, Romania
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Romania, Russian Federation, Chile, Sweden, Spain, Hungary, Czechia, Norway
-
SanofiCompletedHypertensionUnited States, Canada, Brazil, Poland, Russian Federation, Germany, Italy, Netherlands, Portugal, Spain, Turkey, Malaysia, Singapore, Taiwan, Mexico, Argentina, Korea, Republic of, Chile, Hong Kong, South Africa, Greece
-
PfizerCompletedPulmonary Disease, Chronic ObstructiveUnited States, Sweden, Australia, Hungary, Bulgaria, South Africa, Poland, Slovakia, India, Canada, Argentina, Czech Republic, Chile, New Zealand, United Kingdom
-
Brigham and Women's HospitalEastern Research GroupCompletedHypertension | Diabetes Mellitus | Metabolic Syndrome | Chronic DiseaseUnited States
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseRussian Federation, United Kingdom, Spain, Germany, Argentina, Italy, Netherlands, Switzerland, Turkey, France, Czech Republic, Hungary, Slovakia, Peru, Korea, Republic of, Colombia, Israel, Chile, Denmark, Ecuador, Egypt, Estonia, ... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Romania, Ukraine, United States, Chile, Greece, Peru
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisSpain, United States, Canada, Korea, Republic of, Australia, Italy, United Kingdom, Germany, China, Finland, Denmark, Netherlands, Greece, Argentina, Austria, Chile, Czechia, Hungary, Japan, Poland, Russian Federation, Ukraine
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveArgentina, Germany, Russian Federation, Ukraine, United States, South Africa, Korea, Republic of, Romania, Canada, France, Italy, Chile, Denmark
-
NovartisCompletedChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Germany, Russian Federation, France, Israel, Korea, Republic of, Italy, Poland, Chile, Mexico, Peru, Canada, Hungary, Netherlands, New Zealand
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Argentina, Bulgaria, Chile, China, Czechia, Hungary, Israel, Poland, Taiwan, Canada, Portugal, United Kingdom, Korea, Republic of, Japan, Slovakia, South Africa
-
TakedaCompletedEssential HypertensionUnited States, Chile, Mexico
-
University of British ColumbiaCanadian Institutes of Health Research (CIHR); Sunnybrook Research InstituteCompletedGestational HypertensionCanada, United Kingdom, Netherlands, United States, Israel, Australia, Chile, New Zealand, Hungary, Poland, Jordan, Argentina, Brazil, Colombia, Estonia
-
Trevi TherapeuticsRecruitingIdiopathic Pulmonary FibrosisUnited Kingdom, Australia, Netherlands, Spain, Italy, Turkey, Poland, Chile, Canada, Germany
-
Boehringer IngelheimCompletedPulmonary FibrosisUnited States, Canada, Chile, China, Finland, France, Germany, Greece, India, Japan, Korea, Republic of, Mexico, Netherlands, Portugal, Russian Federation, Spain, Turkey
-
TakedaCompletedHypertensionUnited States, Mexico, Chile, Peru
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
Cynthia WestCompletedHypertension | Cardiovascular Disease | Diabetes | Carotid Atherosclerosis | HyperlipidemiaUnited States
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, Australia, Germany, United Kingdom, China, Philippines, Italy, Chile, Taiwan, Thailand, France, Puerto Rico, Israel, Peru, Colombia, Poland, Brazil, Russian Federation, Romania, Greece
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Russian Federation, Chile, South Africa, Romania, Mexico, Norway
-
Boehringer IngelheimCompletedHypertensionUnited States, Argentina, Canada, Chile, Mexico, Peru
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Japan, Russian Federation, Chile, Poland, Mexico, Estonia, Korea, Republic of, Philippines
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary DiseaseUnited States, Belgium, Australia, Israel, Spain, France, United Kingdom, Denmark, Argentina, Germany, New Zealand, South Africa, Korea, Republic of, Poland, Bulgaria, Canada, Chile, Czechia, Netherlands, Romania, Sweden, Mexico
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, Denmark, United States, Australia, Canada, Germany, Netherlands, Poland, Spain, United Kingdom, Korea, Republic of, Philippines, Italy, Argentina, Belgium, Bulgaria, Czechia, Finland, Hungary, India, Japan, Mexico, Norway, Port... and more
-
Boehringer IngelheimCompletedPulmonary FibrosisSpain, Belgium, Canada, Germany, China, United Kingdom, Australia, Ireland, Italy, Mexico, Netherlands, Portugal, Argentina, France, Russian Federation, Greece, Czechia, Brazil, Bulgaria, Chile, Hungary
-
SanofiRegeneron PharmaceuticalsRecruitingChronic Obstructive Pulmonary DiseaseBulgaria, China, United States, Argentina, Chile, Czechia, Georgia, Greece, Hungary, India, Israel, Italy, Mexico, Poland, Romania, Russian Federation, Slovakia, Taiwan, Ukraine, United Kingdom, Mauritius
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Germany, Romania, Bulgaria, Argentina, Canada, Chile, Philippines, South Africa, Thailand, Netherlands, Korea, Republic of, Hungary, United Kingdom
-
Genentech, Inc.Active, not recruitingChronic Obstructive Pulmonary DiseaseUnited States, Israel, Australia, Denmark, Korea, Republic of, Spain, Belgium, France, Bulgaria, Poland, United Kingdom, Germany, Canada, Netherlands, Peru, Argentina, Hong Kong, South Africa, New Zealand, Sweden, Czechia, Chile, Ro... and more
-
Hoffmann-La RocheRecruitingChronic Obstructive Pulmonary Disease (COPD)United States, China, Spain, Italy, Belgium, Korea, Republic of, Poland, Taiwan, Israel, United Kingdom, Japan, Czechia, New Zealand, Philippines, Hong Kong, Greece, Australia, Thailand, Netherlands, Argentina, France, India, Canada, ... and more
-
AstraZenecaRecruitingCOPD (Chronic Obstructive Pulmonary Disease)France, Denmark, Italy, Spain, United States, Canada, Argentina, Japan, Colombia, Germany, Peru, Brazil, China, India, Thailand, Austria, Serbia, Malaysia, Philippines, Poland, Taiwan, Greece, Norway, Sweden, Mexico, Romania, Korea, Republic... and more
-
Bristol-Myers SquibbCompletedIdiopathic Pulmonary FibrosisUnited States, Mexico, Australia, Colombia, Chile, Peru
-
Boehringer IngelheimCompletedIdiopathic Pulmonary FibrosisUnited States, Spain, Korea, Republic of, Belgium, Australia, United Kingdom, Canada, China, Germany, Japan, Turkey, France, Ireland, Italy, Israel, Netherlands, Portugal, Greece, India, Czechia, Chile, Finland, Mexico, Russian Federation
-
AstraZenecaRecruitingChronic Obstructive Pulmonary Disease (COPD)China, United States, Denmark, Italy, Canada, Germany, Hungary, Netherlands, Spain, United Kingdom, Belgium, Argentina, Bulgaria, India, Japan, Vietnam, Malaysia, Thailand, Korea, Republic of, Mexico, Brazil, Greece, Poland, France, Peru, Chil... and more
-
GlaxoSmithKlineCompletedPulmonary Disease, Chronic ObstructiveUnited States, Australia, Argentina, Germany, Spain, South Africa, Mexico, Peru, Netherlands, Canada, United Kingdom, Denmark, Chile, Italy, Sweden